Company intelligence / Profile preview

Pendopharm

Montreal, Quebec, Canadapharmascience.com ↗

Ownership: Private
Employees: ~48
Development stage: Commercial

Overview

Pendopharm commercializes more than 40 specialty pharmaceutical products in Canada. The company focuses on both branded and established medicines across several therapeutic areas. It actively licenses and partners to bring innovative treatments to market. Recent activities include investment in Edesa Biotech and licensing novel anorectal treatments for the Canadian market. Clinical results for specific programs are not detailed publicly.

Therapeutic areas: OtherGastroenterologyImmunologyInfectious Diseases
Modalities: Small moleculesprescription medicinesover-the-counter (OTC) products
Industry: Biotech

Partnerships

Edesa Biotech Inc. – investment and product licensing partnership

Beyond the preview

Go deeper on Pendopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pendopharm.

Explore the full profile